Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 8.47
-5.89 %
$ 3.91 B
Market Cap
-9.85
P/E
Price Target
Average
18.06%
Revenue Forecast
Estimate
13.11%
EBIT
Estimate
--19.29%
Net Income
Estimate
41.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Amneal Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for AMRX of $10 , with forecasts ranging from a low of $8 to a high of $12 .
AMRX Lowest Price Target
Wall Street Target
8 USD
-5.55%
AMRX Average Price Target
Wall Street Target
10 USD
18.06%
AMRX Highest Price Target
Wall Street Target
12 USD
41.68%
REVENUE FORECAST
Revenue Forecast Chart AMRX
EBIT FORECAST
EBIT Forecast Chart AMRX
NET INCOME FORECAST
Net Income Chart AMRX